A phase 1 study of the selective cyclin dependent kinase inhibitor P276-00 in patients with advanced refractory neoplasms Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hirte, HW
  • Raghunadharao, D
  • Baetz, T
  • Hotte, Sebastien
  • Rajappa, S
  • Iacobucci, A
  • Sharma, S
  • Parikh, H
  • Kulkarni, S
  • Patil, S
  • Gaston, S

publication date

  • June 20, 2007